Evogene ltd. (EVGN)
Income statement / Yearly
Dec'17Dec'16Dec'15
Revenues

3,381

6,540

11,129

Cost of revenues

2,845

5,639

8,255

Gross profit

536

901

2,874

Operating expenses:
Research and development, net

16,987

16,405

14,449

Business development

1,686

1,696

1,964

General and administrative

3,810

3,889

4,382

Total operating expenses

22,483

21,990

20,795

Operating loss

-21,947

-21,089

-17,921

Financing income

2,125

2,424

2,571

Financing expenses

1,005

891

1,863

Loss before taxes on income

-20,827

-19,556

-17,213

Taxes on income

11

36

0

Net loss

-20,838

-19,592

-17,213

Other comprehensive income (loss):
Loss from cash flow hedges

0

0

-45

Amounts transferred to the statement of profit or loss for cash flow hedges

0

0

267

Total comprehensive loss

-20,838

-19,592

-16,991

Basic and diluted net loss per share

-0.81

-0.77

-0.68